China Approves Clinical Trials for COVID-19 Vaccine... Recruiting Participants
[Asia Economy Beijing=Special Correspondent Park Sun-mi] Just one day after the United States announced news of its COVID-19 vaccine clinical trials, China also revealed that its application for clinical trials of a domestically developed vaccine has received government approval.
On the 18th, China’s Global Times reported that military researchers in Wuhan, Hubei Province, who have been dedicated to developing a COVID-19 vaccine, have passed the registration review for clinical trials and only the trial execution remains.
The vaccine development team is led by Colonel Chen Wei of the Military Medical Research Institute, who previously developed the world’s first gene-based Ebola vaccine in 2014. The team jointly developed this vaccine with CanSino Biologics, a biotechnology company headquartered in Tianjin, China.
Colonel Chen stated that the vaccine has been standardized according to international standards and Chinese regulations, and that preparations are already in place to ensure the vaccine is safe, effective, and capable of mass production. Currently, CanSino Biologics is recruiting participants for a six-month clinical trial.
The Global Times emphasized that China announced approval for clinical trials of its domestically developed vaccine just 19 hours after the United States announced the start of human trials for its COVID-19 vaccine, stating that "the two countries are on equal footing in the vaccine development race."
It added, "Due to China’s systemic advantages, the speed of commercializing the vaccine is expected to surpass that of the United States," and noted, "The military research team not only possesses abundant research capabilities but also faces fewer restrictions on experimental conditions, which is advantageous for vaccine development."
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Jung Won-oh Vows to Prioritize Youth Housing by Cutting Wasteful Budgets Like Mayor's Garden and Han River Bus
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Meanwhile, Hong Kong’s South China Morning Post (SCMP) reported that the COVID-19 vaccine jointly developed by the Chinese military research team and CanSino Biologics is at the forefront of clinical trial applications, and that there are currently nine COVID-19 vaccines under development in China.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
